Abstract
Purpose
Cachexia is common in patients with thoracic cancer impairing physical function and quality of life. New approaches which target muscle tissue are emerging and activity monitors could provide an objective assessment of their effect on physical function. We have collated data from three studies involving the use of one such monitor in order to benchmark aspects of physical activity for patients with thoracic cancer, explore how these relate to physician-rated performance status, and consider the implications for future studies.
Methods
Patients with thoracic cancer and an Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0–2 wore an ActivPAL™ monitor for 1 week. The mean time spent each day in a range of activities, e.g. standing or step**, or their frequency, e.g. number of sit-to-stand transitions, steps taken, were calculated and compared according to ECOG PS.
Results
Data from 84 patients (54 male; mean (SD) age, 66 (9) years) were collated. Each day, patients spent a mean (SD) of 4.3 (2.0) h upright, completed 45 (17) sit-to-stand transitions and took 4,246 (2,983) steps. There was wide variation in each activity examined. All but the number of sit-to-stand transitions differed significantly between ECOG PS categories.
Conclusions
These data provide a detailed insight into how physical activity levels decline across the range of ECOG PS categories studied. The wide variation in physical activity within each ECOG PS category suggests that this scale may lack sufficient sensitivity to evaluate new cachexia treatments. Our data help to inform future work in this area.
References
Laviano A, Meguid MM, Inui A, Muscaritoli M, Rossi-Fanelli F (2005) Therapy insight: cancer anorexia–cachexia syndrome—when all you can eat is yourself. Nat Clin Pract Oncol 2:158–165
Fearon K, Strasser F, Anker SD et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. doi:10.1016/S1470-2045(10)70218-7
Dodson S, Baracos VE, Jatoi A, Evans WJ, Cella D, Dalton JT, Steiner MS (2011) Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Ann Rev Med 62:265–279
Mantovani G, Madeddu C, Serpe R (2010) Improvement of physical activity as an alternative objective variable to measure treatment effects of anti-cachexia therapy in cancer patients. Curr Opin Supp Pall Care 4(4):259–265
Fearon KCH (2008) Cancer cachexia: develo** multimodal therapy for a multidimensional problem. Eur J Cancer 44:1124–1132
Maddocks M, Byrne A, Johnson CD, Wilson RH, Fearon KCH, Wilcock A (2009) Physical activity level as an outcome measure for use in cancer cachexia trials: a feasibility study. Supp Care Cancer 18:1539–1544
Grant PM, Ryan CG, Tigbe WW, Granat MH (2006) The validation of a novel activity monitor in the measurement of posture and motion during everyday activities. Br J Sports Med 40:992–997
Ryan CG, Grant PM, Tigbe WW, Granat MH (2006) The validity and reliability of a novel activity monitor as a measure of walking. Br J Sports Med 40:779–784
Maddocks M, Petrou A, Skipper L, Wilcock A (2010) Validity of three accelerometers during treadmill walking and motor vehicle travel. Br J Sports Med 44:606–608
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 5:649–655
Dupont WD, Plummer WD (1990) Power and sample size calculations: a review and computer program. Controlled Clinical Trials 11:116–128
Tudor-Locke C, Washington TL, Hart TL (2009) Expected values for steps/day in special populations. Prevent Med 49:3–11
Dahele M, Fearon KCH, Preston T, Skipworth RJE, Voss A, Wall L (2007) Objective physical activity and self-reported quality of life in patients receiving palliative chemotherapy. J Pain Symptom Manage 33:676–685
Dajczam E, Kasymjanova G, Kreisman H, Swinton N, Pepe C, Small D (2008) Should patient-rated performance status affect treatment decisions in advanced lung cancer? J Thorac Oncol 3:1133–1136
Acknowledgments
This work was supported by funding from the Nottinghamshire, Leicestershire and Derbyshire Research Alliance, Cancer Research UK (C18598/A8211) and the National Cancer Research Institute (LCSuPaC 35).
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maddocks, M., Wilcock, A. Exploring physical activity level in patients with thoracic cancer: implications for use as an outcome measure. Support Care Cancer 20, 1113–1116 (2012). https://doi.org/10.1007/s00520-012-1393-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-012-1393-z